Latest Insider Transactions at Cns Pharmaceuticals, Inc. (CNSP)
This section provides a real-time view of insider transactions for Cns Pharmaceuticals, Inc. (CNSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CNS Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CNS Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2024
|
John M Climaco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
166,666
+43.59%
|
$0
$0.3 P/Share
|
|
Feb 01
2024
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
66,666
+39.19%
|
$0
$0.3 P/Share
|
|
Feb 01
2024
|
Carl Anthony Evans Director |
BUY
Open market or private purchase
|
Direct |
33,333
+49.91%
|
$0
$0.3 P/Share
|
|
Feb 01
2024
|
Jerzy Gumulka Director |
BUY
Open market or private purchase
|
Direct |
33,333
+43.66%
|
$0
$0.3 P/Share
|
|
Aug 22
2023
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
27,000
+42.34%
|
$27,000
$1.27 P/Share
|
|
Aug 16
2023
|
John M Climaco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,750
+5.31%
|
$2,750
$1.8 P/Share
|
|
Apr 28
2023
|
Christopher Downs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+5.06%
|
-
|
|
Apr 28
2023
|
John M Climaco Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+2.63%
|
-
|
|
Apr 19
2023
|
Jerzy Gumulka Director |
BUY
Open market or private purchase
|
Direct |
2,500
+20.54%
|
$2,500
$1.7 P/Share
|
|
Apr 17
2023
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,100
+25.1%
|
$9,300
$3.2 P/Share
|
|
Apr 12
2023
|
John M Climaco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+25.0%
|
$0
$0.69 P/Share
|
|
Apr 10
2023
|
Jerzy Gumulka Director |
BUY
Open market or private purchase
|
Direct |
7,173
+50.0%
|
$0
$0.74 P/Share
|
|
Mar 28
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
10,000
-6.0%
|
$10,000
$1.04 P/Share
|
|
Mar 27
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.91%
|
$5,000
$1.09 P/Share
|
|
Mar 24
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.83%
|
$5,000
$1.08 P/Share
|
|
Mar 23
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
10,000
-5.35%
|
$10,000
$1.08 P/Share
|
|
Mar 22
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.61%
|
$5,000
$1.08 P/Share
|
|
Mar 21
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.54%
|
$5,000
$1.1 P/Share
|
|
Mar 20
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.48%
|
$5,000
$1.08 P/Share
|
|
Mar 17
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.42%
|
$5,000
$1.13 P/Share
|
|
Mar 16
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.36%
|
$5,000
$1.24 P/Share
|
|
Mar 15
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.31%
|
$5,000
$1.22 P/Share
|
|
Mar 14
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.25%
|
$5,000
$1.35 P/Share
|
|
Mar 13
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.2%
|
$5,000
$1.3 P/Share
|
|
Mar 10
2023
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,000
-2.16%
|
$5,000
$1.29 P/Share
|
|
Dec 09
2022
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
2,798
-1.19%
|
$5,596
$2.43 P/Share
|
|
Dec 08
2022
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,500
-2.29%
|
$11,000
$2.4 P/Share
|
|
Dec 07
2022
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,500
-2.24%
|
$11,000
$2.46 P/Share
|
|
Dec 06
2022
|
Waldemar Priebe |
SELL
Open market or private sale
|
Indirect |
5,500
-2.19%
|
$11,000
$2.47 P/Share
|
|
Mar 11
2022
|
Christopher Downs Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+15.17%
|
$0
$0.31 P/Share
|
|
Mar 08
2022
|
Carl Anthony Evans Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+50.0%
|
$0
$0.27 P/Share
|
|
Mar 07
2022
|
Jeffry R. Keyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,100
+50.0%
|
$0
$0.3 P/Share
|
|
Mar 07
2022
|
John M Climaco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+3.59%
|
$0
$0.28 P/Share
|
|
Dec 06
2021
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+3.19%
|
$0
$0.94 P/Share
|
|
Nov 19
2021
|
Christopher Downs Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,500
+2.98%
|
$4,500
$1.15 P/Share
|
|
Nov 16
2021
|
John M Climaco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.55%
|
$5,000
$1.28 P/Share
|
|
May 05
2020
|
Waldemar Priebe |
SELL
Other acquisition or disposition
|
Indirect |
1,495,867
-16.57%
|
-
|